disclosure i, peter t. katzmarzyk, phd, facsm, have no relationships with commercial interests to...

17
Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. LSU SCHOOL OF MEDICINE- NEW ORLEANS

Upload: maliyah-caldwell

Post on 14-Dec-2015

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Disclosure

I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose.

A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

LSU SCHOOL OF MEDICINE-NEW ORLEANS

Page 2: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Peter T. Katzmarzyk, PhD, FACSM

Associate Executive Director for Population ScienceProfessor and Louisiana Public Facilities Authority Endowed Chair

Pennington Biomedical Research CenterBaton Rouge, LA

Page 3: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

LSU’s Improving Clinical Outcomes Network (LSU ICON), led by Pennington Biomedical, represents the joint efforts of several of the Louisiana State University

academic health science and health care delivery institutions to improve the care of patients in Louisiana.

Page 4: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

A VALUE PROPOSITION

In the context of national health care reform, health care providers are expected to be more accountable for

the care they deliver from the perspectives of cost, quality and patient satisfaction. With these expectations, the infrastructure

necessary to coordinate efforts across Louisiana for the purposes of improved quality and efficiency must be substantially

enhanced in order to deliver higher value for patients.

Page 5: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
Page 6: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
Page 7: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
Page 8: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

LSU ICON Steering Committee

Peter T. Katzmarzyk, PhDAssociate Executive Director for Population Science,Pennington Biomedical

Donna Ryan, MDAdjunct Professor,Pennington Biomedical

Pat F. Bass III, MD, MS, MPHAssociate Professor,Internal Medicine & Pediatrics,LSUHSC- Shreveport

William T. Cefalu, MDAssociate Executive Director for Clinical Research,Pennington Biomedical

Fred Cerise, MD, MPHVice President for Health Affairs & Medical Education,LSU Health

Terry Fontham, MPH, DrPHDean, School of Public Health LSU Health New Orleans

Mike Kaiser, MD, FAAPChief Medical Officer, LSU Health

Ronald Horswell, PhDAssociate Professor, Pennington Biomedical

Wayne A. Wilbright, MD, MSChief Medical InformationOfficer, LSU Health

Page 9: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Idea and Knowledge GenerationPilot

ProjectSubmissions

Pilot Projects

ICON Intramural

Projects

ICON Infrastructure

Health Care Quality Improvement

SteeringCommittee

Community Engagement

Health CareProvider

Engagement

Page 10: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
Page 11: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Administrative Core

• planning, evaluation and tracking of the LSU ICON enterprise

• facilitation of communication across the other four Cores

• coordinates the Steering Committee, Health Literacy component and Pilot Projects

• tracking and compliance staff monitor adherence to Good Clinical Practice guidelines, Human Subjects Protection, HIPAA and privacy rules across all LSU ICON Cores

Page 12: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Medical Informatics Core

• The primary function is to support quality improvement projects throughout the LSU Health System through the use of informatics applied in a uniform and systematic approach across all units.

The Core has the following services available:• Support projects involving LSU clinical and administrative data (DMED, Pelican) • Support access to external data sources (e.g. LTR, OPH death registry) • Support incorporation of new data types into projects • Support direct use of retrospective data by investigators (L-DMED) • Support background research for project design• Acquisition of naturally-arising project outcomes data• Maintenance of disease and population registries• Develop/maintain databases for prospective projects

Page 13: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Design and Analysis Core

• composed of biostatistics, epidemiology and community health personnel

This Core serves three functions, as follows:

• generates ideas and tests hypotheses using data from patients being served in the LSU hospitals and clinics

• provides consultation in statistical issues of design and analysis of clinical outcomes projects which emanate from LSU ICON

• the Community Health Specialists will support multiple LSU ICON projects by consulting on the design of projects that include behavior modification

Page 14: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Network Evaluation Support Team

• encompasses Patient Interaction Specialists and other personnel who interact with patients in the LSU hospitals and clinics

• Patient Interaction Specialists are responsible for implementing collecting and maintaining data from LSU ICON clinical and health services projects

• Patient Interaction Specialists are embedded in the individual performance sites and can screen potential subjects for protocol eligibility, present project concepts and details to the patients, participate in the informed consent process, and enroll patients into LSU ICON projects

Page 15: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Medical Consultants Core

• comprised of physicians and behavioral psychologists who are highly experienced in methodology of clinical projects.

• can be used as a resource to those healthcare providers and LSU faculty requesting mentoring with projects involving improving clinical outcomes or improving health services under LSU ICON.

• responsible for stimulating ideas among the LSU ICON institutions, for guiding and refining project ideas and encouraging new projects to come from the field.

Page 16: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

Round 1 Pilot Projects

56 letters of intent were received

17 full applications were solicited

2-4 pilot projects will be funded

Round 2 will be advertised in March/April.

Page 17: Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,

www.LSUICON.org